Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Troax Group: Invitation – first quarter results presentation 2017

Invitation, Hillerstorp 4 May 2017, 08:30 CET Troax Group´s report for the first quarter 2017 will be published at 12:30 CET, May 10. The report and a presentation will be available on http://www.troax.com/en/investors/investorsThomas Widstrand, President and CEO, will present the financial results on a conference call the same day at 17:00 CET. The conference will be held in English. In order to participate in the conference call, please use the dial-in details below. Callers are encouraged to dial in 5-10 minutes in advance as a short registration with the call operator is

Development of city logistics in Arenastaden

As part of our ambition to be actively involved in city district development, Fabege is launching a sustainable logistics network in which deliveries, returns management and recycling will be handled in a single flow. The aim is to reduce the amount of transportation in the area and promote greener districts.Fabege is teaming up with Catena, Ragn-Sells and Servistik to form the company Urban Services i Solna AB (Urban Services), which will be owned equally by all four parties. The company will offer logistics and other services primarily aimed at property owners, tenants and residents.

Episurf Medical AB will participate at 26. Thüringer Unfallchirurgisch-Orthopädisches Symposium , held in Apolda, Germany, on May 19-20

Episurf Medical AB will participate at 26. Thüringer Unfallchirurgisch-Orthopädisches Symposium, an orthopaedic conference held in Apolda, Tyskland, (Stadthalle) on May 19-20 and the event is arranged by Verband leitender Orthopäden und Unfallchirurgen (VLOU) e.V. Regionalverband Thüringen. For full program, see link. . For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences). For more information, please contact: Pål Ryfors, acting CEO, Episurf Medical

Viking Supply Ships AB (publ) Interim report Q1 2017

Press releaseFIRST QUARTER                       · Total revenue from continuing operations was MSEK 90 (233) · EBITDA from continuing operations was MSEK -61 (65) · Result after tax including discontinued operations was MSEK -2 (-40) · Result after tax per share including discontinued operations was SEK 0.0 (-0.2) SUMMARY OF EVENTS IN Q1 · EBITDA for Q1 from continuing operations was MSEK -61 (65). · The average fixture rate in Q1 was USD 36,400 (63,600) for the AHTS fleet and USD 0 (6,200) for the PSV fleet. The average utilization in Q1 was 23% (56) for the AHTS

Invitation to presentation of the interim report for the first quarter 2017

Net Gaming invites media, analysts and investors to the presentation of the interim report for the first quarter 2017. The presentation starts on Thursday 18th May 2017 at 10:00 CET.CEO Marcus Teilman will present the report and the presentation will be held in English followed by a question and answer section. It is not possible to participate via live streaming or phone. The presentation will be held at Selected Office at Artillerigatan 6 in Stockholm, Sweden. Registration for attending the presentation is made by email to info@netgaming.se. For further information, please contact:

ABB technologies to support smart city development in South Africa

Zurich, Switzerland, May 4, 2017 - Wireless communication and software technologies to enhance connectivity and power supply reliability in DurbanABB will provide a seamless wireless network connectivity to an industrial area within Durban, South Africa’s third most populated city with more than 3 million people. Durban is also one of the country’s major manufacturing hubs and South Africa’s busiest port. This high capacity field area network will complement eThekwini’s existing fiber optic back-haul network and strengthen its resilience to face up to a tropical climate characterized by

Archer Limited : First Quarter 2017 Trading Update

Hamilton, Bermuda (May 4, 2017) First quarter 2017 highlights  · Archer agreed the terms of a comprehensive debt refinancing and raised $100 million in a private placement. · First quarter revenue was $201.6 million. · First quarter underlying EBITDA was $17.3 million, excluding restructuring costs of $2.4 million. · Net loss was improved by $26 million from $48.3 in fourth quarter 2016 to $22.3 million in first quarter 2017. · US operations experienced significant increase in activity. · Archer Oiltools secured frame agreements with Statoil. Subsequent event

Utilization of transfer authorization in Investor AB to secure costs for the Company’s long-term variable remuneration programs

The Annual General Meeting 2017 decided to authorize the Company’s Board to decide on the transfer of the Company’s own shares in order to secure commitments and costs for Investor’s long-term variable remuneration program and for the issue of synthetic shares as part of the Board remuneration. Investor hereby announces that the Company’s Board has decided to utilize the authorization for these purposes. The transfer of own shares may take place on NASDAQ Stockholm during the period from May 4, 2017 up to and including May 8, 2018 at a price within the from time to time registered price

A new share-based long-term incentive program for the top management of Exel Composites

EXEL COMPOSITES PLC     STOCK EXCHANGE RELEASE     4 MAY 2017 at 09:15 EETThe program The Board of Directors of Exel Composites Plc has decided on the establishment of a new share-based long-term incentive program for the top management of Exel Composites. The objectives of the program are to align the interests of the management with those of the company’s shareholders and, thus, to promote shareholder value creation in the long term, to commit the management to achieving the strategic targets of the company and to retain the company’s valuable key individuals. The program

Interim report for Q1 2017

Strong financial start in 2017. Revenue grew 58 % in the first quarter and we reached an EBITDA margin of 33 %. The reason for the improved results, besides a new licensing deal, is that we have higher revenues from C.R. Bard and continued cost control. The volume of products sold from our own portfolio is lower than last year, but the product mix makes the value still in line with the previous year. The first quarter’s main event was the licensing deal with Smartwise which opens up a whole new area of application for our technology. Marketwise, the first quarter was primarily characterized

Annual General Meeting of BioGaia

The Annual General Meeting of BioGaia AB (publ) on 3 May 2017 voted to approve the following resolutions: · adoption of the annual report · discharge from liability for the Board members and the Managing Director · a dividend of SEK 7.50 per share · re-election of Board members Jan Annwall, Ewa Björling, David Dangoor, Stefan Elving, Inger Holmström, Anthon Jahreskog and Brit Stakston · New election of Margaretha Gadnell as Board member · Margaretha Gadnell, born in 1959, has a B.Sc in Chemistry from Linköping University. She has many years of experience from senior

Cxense ASA - Voting disclosure

This notice is issued by Cxense ASA ("Cxense") on behalf of persons with disclosure obligation. Morten Opstad, Chairman of the Board of Directors of Cxense ASA, who shall also open the Annual General Meeting on 10 May 2017, had until this afternoon received powers of attorney to represent and vote for a total of 1,112,758 shares at the upcoming Annual General Meeting (AGM) on 10 May 2017, corresponding to 13.98% of the share capital and the voting rights of the company. The powers of attorney are only valid at the Annual General Meeting. Marc O Polo Norge AS, controlled by Morten

INTERIM REPORT 1 JANUARY-31 MARCH 2017

First quarter in brief · Net sales for the quarter amounted to MSEK 44 (136). · Operating profit before depreciation and amortisation (EBITDA) was MSEK 21 (40), of which associates had an impact of MSEK 0 (0) on the Group. Operating cash flow was MSEK 47 (82). · Profit/loss before tax totalled MSEK -20 (-7). · Proft/loss after tax totalled MSEK -20 (-3), or SEK -0.58 (-0.08) per share. · Production totalled 185 GWh (164), of which Own wind power operations accounted for 93 GWh (88), and Co-owned wind power operations for 92 GWh (76). · Average income from Own wind power

Exel Composites Plc’s January – March Business Review 2017: “Significant improvement in operating profit”

EXEL COMPOSITES PLC            STOCK EXCHANGE RELEASE            4 MAY 2017 at 09:00 EETQ1 2017 in brief ·  Order intake increased by 24.7% to EUR 22.5 million (Q1 2016: 18.0). ·  Revenue increased by 13.3% to EUR 20.3 million (17.9). ·  Operating profit amounted to EUR 1.7 million (0.1), which is 8.2% of revenue (0.8%). ·  Net cash flow from operating activities was EUR -0.8 million (-0.9). ·  Earnings per share amounted to EUR 0.09 (0.00). Outlook for full year 2017 Exel Composites reiterates its outlook for 2017 and estimates that revenue with current company

SciBase receives US patent for Nevisense electrode design

May 2nd SciBase received patent approval for a further US patent.On May 2nd 2017 SciBase received confirmation that US patent number 9,636,035 has been approved. The patent protects the unique shape of the microneedles that enable detection of malignant melanoma in the skin using electrical impedance as demonstrated with high precision in clinical trials. In total SciBase now has 3 patent families approved in the US and an additional family in process. ”Our electrode design is one of the key reasons for the success of our method. It is positive that we further strengthen our patent

WULFF GROUP PLC’S INTERIM REPORT FOR JANUARY 1 – MARCH 31, 2017

INTERIM REPORT     May 4, 2017 at 9.00 A.M. Wulff’s profitability improved, the decrease in net sales ended and remained at previous year’s level This is a summary of Wulff Group Plc’s interim report for January-March 2017. Wulff Group’s interim report for January-March 2017 is attached as a  PDF file to this stock exchange release and is also available on the company’s website at the address www.wulffyhtiot.fi. KEY POINTS JANUARY – MARCH 2017 · Net sales totalled EUR 15.3 million (EUR 15.5 million). Net sales decreased by 1.0 percentages from the previous year. · EBITDA

Tradedoubler interim report January – March 2017

Further improved profitability  THE FIRST QUARTER JANUARY – MARCH 2017  · Net sales amounted to SEK 336 M (372). Net sales adjusted for change related items were SEK 336 M (372), which was a decrease of 10%.  · Gross profit adjusted for change related items was SEK 72 M (81), a decrease of 11% or 10% adjusted for changes in exchange rates. Gross margin adjusted for change related items was 21.5% (21.7).  · Operating costs excluding depreciation and change related items were SEK 64 M (85), a decrease of 24%.  · EBITDA amounted to SEK 7 M (-5). Adjusted for change related

Guido Oelkers appointed President and CEO at Sobi

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces that Guido Oelkers has been appointed President and Chief Executive Officer effective as of 22 May 2017, succeeding Geoffrey McDonough.  Guido Oelkers joins Sobi from his previous role as CEO at BSN Medical GmbH. He has extensive experience from pharmaceutical and health care companies including a role as President and CEO of the Swedish medtech company Gambro, CEO of the specialty pharmaceutical company Invida and a number of executive commercial operations roles in companies such as Nycomed, DKSH Group

There are no items matching the current filter
There are no more items matching the current filter
Back to top